Leuven (BELGIUM) - January 24, 2014 - TiGenix (NYSE Euronext: TIG), a leader in the field of cell therapy, announced today that it has signed an agreement for the sale of its state-of-the-art Dutch ...

Leuven (BELGUIM) - July 5, 2016, 8:00h CEST - TiGenix NV (Euronext Brussels: TIG), an advanced biopharmaceutical company focused on the development and commercialization of novel therapeutics based on ...

TiGenix has taken another step toward its delayed Nasdaq IPO. The stem cell therapy specialist is aiming to net $42.9 million (€39.8 million) through the listing, approximately half of which will go ...

Takeda is to acquire TiGenix, the stem cell specialist biotech with which it has developed a gastro stem cell therapy, in a deal worth 520 million euros ($626 million). The decision follows backing ...

BRUSSELS (Reuters) – Belgian biotech company TiGenix said on Tuesday it was in advanced discussions to sell its Dutch manufacturing facility and separately to find a partner for its candidate ...

Takeda Pharmaceutical submitted a voluntary conditional takeover bid for TiGenix, a biopharmaceutical company developing stem cell therapies for anti-inflammatory disease. The waiting period ...

Less than a week after stumping up cash for a one-drug-wonder biotech (and an option to buy it out), Japan’s Takeda has struck another biotech deal, this time with Belgium-based TiGenix. But it's not ...

Takeda Pharmaceutical Co. acquired 90.83 percent of TiGenix’s voting rights through its previously announced takeover effort. 1. Takeda closed its first bid, agreeing to buy TiGenix’s shares on a ...

TiGenix has sold to Takeda ex-U.S. rights to its stem cell treatment Cx601 for complex perianal fistulas in patients with Crohn's disease—an up-to-€390 million ($435 million)-plus deal reflecting what ...

TiGenix has also completed a phase 2a trial in refractory Rheumatoïd Arthritis patients and initiated in 2014 a phase 1b trial in severe Sepsis. Both of these indications are treated via intravenous ...

About Alofisel (darvadstrocel) Alofisel is a local administration of allogeneic (or donor derived) expanded adipose-derived stem cells (eASCs) for the treatment of complex perianal fistulas in adult ...